This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Helicobacter Pylori Non-Invasive Testing Market

Rising government funding and research initiatives are setting the stage for non-invasive testing for Helicobacter pylori

Helicobacter Pylori Non-Invasive Testing Market by Non-invasive Test Type, Test, End User & Region - Forecast 2022 - 2033

Helicobacter Pylori Non-Invasive Testing Market Outlook 2022 - 2033

The global helicobacter pylori non-invasive testing market is projected to register at a moderate-paced CAGR of 4.4% over the forecast period. The helicobacter pylori non-invasive testing market is currently valued at US$ 650.50 Mn in 2023. By 2033, demand for helicobacter pylori non-invasive testing is expected to reach a high of US$ 1000.57 Mn.

This growth in the adoption of helicobacter pylori non-invasive testing is supported by the following:

  • Non-invasive testing has become increasingly popular for identifying H. pylori infections.
  • The dearth of endoscopic resources
  • Infection awareness among governments is growing, which is important for getting a proper diagnosis.
  • A dramatic increase in the need for point-of-care testing devices
  • The accessibility of diagnostic tools.
Customize this Report

Let us know your requirement to get
100% FREE customization

Immunoassay Market’s Projected Growth in the Upcoming Years

Immunoassays are biochemical tests that determine how much of an analyte is present. It doesn't matter what size the analyte is; it might be a huge protein, an antibody the body has created in response to an illness, or a little molecule. The accuracy and reliability of immunoassays are unparalleled. They are very specific since antibodies and purified antigens are used as reagents. Diseases can be diagnosed more precisely using this assay since it measures antigen presence. It is a highly selective bioanalytical approach that uses an antibody or antigen as a biorecognition agent to quantify the presence or quantity of analytes ranging from tiny molecules to macromolecules in solution.

Due to the presence of several advanced technologies, such as the enzyme immunoassays, which are used for the detection of antibodies, the immunoassay segment currently holds a significant market share in the helicobacter pylori non-invasive testing market and is expected to show a similar trend over the forecast period. Key factors propelling the immunoassay market are the growing incidence of gastritis and infections caused by Helicobacter pylori, as well as technical developments.

For instance, in 2021, the worldwide prevalence of gastritis was estimated to be between 50.0% and 56.0%, according to a study titled "Diagnosis of Helicobacter pylori Infection and Recent Advances," with the prevalence of chronic atrophic gastritis falling within that range between 20% and 30%. Helicobacter pylori infection was shown to be proportional to gastritis prevalence, and cases of Helicobacter pylori-positive gastritis were found to account for more than 80.0% of all cases. Since such illnesses are typically detected by immunoassays, rising instances of Helicobacter pylori infection and gastritis are expected to drive the segment growth throughout the forecast period.

Market Value (2023)

US$ 650.50 Mn

Market Value (2033)

US$ 1000.57 Mn

CAGR

4.4%

Comparative Analysis of Adjacent Markets

Helicobacter Pylori Non-Invasive Testing Market:

Differentiating Aspects

Helicobacter Pylori Non-Invasive Testing Market

CAGR

4.4%

Market Valuation in 2023

US$ 650.50 Mn

Projected Market Value in 2033

US$ 1000.57 Mn

Drivers

  • The dearth of endoscopic resources
  • Infection awareness among governments is growing, which is important for getting a proper diagnosis.
  • A dramatic increase in the need for point-of-care testing devices
  • The accessibility of diagnostic tools.

Non-invasive Ventilators Market:

Differentiating Aspects

Non-invasive Ventilators Market

CAGR

5.9%

Market Valuation in 2023

US$ 2.2 Bn

Projected Market Value in 2033

US$ 3.9 Bn

Drivers

  • Rising in new cases of COVID cases
  • Increase in government initiatives made leading to increase in research & development activities.
  • Growing initiatives by key market players are expected to offer significant growth opportunities

Serological Testing Market:

Differentiating Aspects

Serological Testing Market

CAGR

16.1%

Market Valuation in 2023

US$ 191.4 Mn

Projected Market Value in 2033

US$ 813.6 Mn

Drivers

  • Increasing prevalence of infectious diseases
  • Growing awareness among the population
  • New technologically advanced product launches.
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Key Drivers and Restraints for the Helicobacter Pylori Non-Invasive Testing Market

Increased Patient Requirement for POC Increases the Demand for H. pylori Tests Drives the Development of the Industry as a Whole

The National Institutes of Health (NIH) research states that IgG serology, the C-Urea Breath Test (UBT), and the monoclonal stool antigen test are all non-invasive, Point-of-care (POC) diagnostic options for primary care settings that can detect H. pylori. UBT is the only one of these that reliably verifies whether an infection is present or has been eradicated. According to the research published in Gut and Liver, UBT is an accurate, non-invasive option that is safe for use on both children and pregnant women.

In addition, H. pylori laboratory test results can now be obtained in a shorter amount of time owing to Point-of-care Testing (POCT), a tried-and-true method. Popularity, the number of people getting tested, and the variety of therapeutic uses for POCTs have all increased as leading companies keep releasing new models. In addition, Point-of-care Testing (POCT) is now widely used in all hospitals and is increasingly being adopted as the norm in other types of healthcare facilities. The global helicobacter pylori non-invasive testing market is expected to expand because of the aforementioned factors throughout the forecast period. This means that the increasing number of H. pylori sufferers is a key factor propelling the helicobacter pylori non-invasive testing market forward.

Industry's growth may be hampered by a lack of educated doctors to perform intrusive tests.

To accurately diagnose Helicobacter pylori infection and determine the best course of therapy, a surgeon or medical professional must perform an invasive procedure that often includes a biopsy and endoscopy. Market growth could be stymied, however, if countries with fewer healthcare resources and a corresponding shortage of trained professionals saw a decline in the number of people getting their diseases checked out. Unfortunately, many nations with a low or middle income lack the hospital and medical training infrastructure necessary to produce highly qualified physicians. However, there are additional difficulties for doctors when treating Helicobacter pylori, as no first-line therapy is effective for everyone.

The helicobacter pylori non-invasive testing market is expected to expand at a modest rate worldwide. Although testing has become more common, diagnosis has been hindered by the fact that HIV infection often has no outward symptoms. This is a major factor in the market's slow expansion. It is also expected that h. pylori non-invasive testing is expected to decrease as attention is redirected to ending the current coronavirus pandemic.

Category-wise Insights

From 2023 to 2033, the clinic market is expected to grow at a CAGR of over 6%, as more people choose clinics over hospitals because of their lower costs and higher quality of care. The reason for this is that people are more likely to seek help from clinics since they offer high-quality care and respond quickly to patient needs, resulting in effective treatment at an affordable price. The premium services provided by clinics as a result of efficient disease management tactics are also expected to fuel market growth.

Due to its non-invasive nature and its ability to offer speedy findings, the POC testing segment accounted for more than 35% of business. This is due, in large part, to rising R&D spending and joint research activities amongst industry heavyweights that are fostering innovation and new product development.

The helicobacter pylori non-invasive testing market may be broken down into two distinct subsegments: invasive helicobacter pylori tests and non-invasive helicobacter pylori tests. Since quick urease tests are both effective and inexpensive, this market subsegment is expected to grow at a CAGR of 6.5% between 2023 and 2032. Patients who do not respond well to antibiotic medication, who have symptoms of severe gastrointestinal issues, and who require gastric endoscopy have a significant demand for invasive diagnostic methods.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Regional Insights

How is the US Helicobacter Pylori Non-Invasive Testing Market Developing?

Globally, North America accounts for the largest helicobacter pylori non-invasive testing market. The expansion of healthcare infrastructure in addition to the rising incidence of stomach cancer, duodenal ulcers, and gastric ulcers in North America are driving forces behind the helicobacter pylori non-invasive testing market's expansion.

The NIH found that 5 percent of U.S. youngsters under the age of 10 have H. pylori in their systems. In addition, 30%-40% of Americans have H. pylori infection, according to research from the US Department of Health and Human Services. Furthermore, socioeconomic variables such as poor income, less education, home crowding, and immigration all contribute to a higher prevalence of H. pylori infection in the US's Hispanic and Black populations. In order to treat H. pylori, the FDA recommends either Proton Pump Inhibitors (PPI) and two antibiotics or bismuth subsalicylate, acid suppressors, and two antibiotics, as detailed in a paper available from the ClinMed International Library.

There is resistance to effectiveness with the currently available first-line medication regimens. Due to resistance in H. pylori to common antibiotics, the United States, for example, observed 75% eradication rates utilising these regimens. The largest rates of resistance are shown with "Clarithromycin" and "Metronidazole," and characteristics related with resistance include race, age, location, and the presence or absence of ulcer disease.

What are the driving factors for the Chinese Helicobacter Pylori Non-Invasive Testing Market?

The market for non-invasive testing for Helicobacter Pylori (H. pylori) in Asia and the Pacific is dominated by China. When it comes to healthcare and pharmaceuticals, China is a developing powerhouse in the Asia-Pacific region. Many international manufacturers of medical, pharmaceutical, and biotechnology products are based in China. High rates of H. pylori infection and gastric (stomach) cancer cases have spurred the development of diagnostic testing kits and technologies for H. pylori detection by pharmaceutical and biotechnology firms.

What are the defining characteristics of the Japanese Helicobacter Pylori Non-Invasive Testing Market?

The Japanese medical industry is among the world's most advanced market. Due to widespread infection with H. pylori and a penchant for consuming smoked and salted foods, Roswell Park Comprehensive Cancer Center reports that Japan has an alarmingly high incidence of stomach cancer. In Japan, 50,000 individuals each year are killed by stomach cancer, making it the third deadliest form of the disease. In addition, 98% of gastric cancer in Japan can be attributed to H. pylori, according to a study published in 2020 in Wiley Online Library.

Recent investigations have indicated that H. pylori infection is the primary cause of stomach cancer, while it is one of many factors. The expansion of the helicobacter pylori non-invasive testing market in Japan is anticipated to benefit from the aforementioned factors over the forecast period.

Competitive Landscape

Companies like DiaSorin S.p.A., Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Alere, Thermo Fisher Scientific, Biomerica, Inc., Certest Biotec S.L., Sekisui Diagnostics, CorisBioconcept SPRL, and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd. are all major players in the global helicobacter pylori maerket. These leaders are anticipated to retain their positions of prominence during the prediction horizon.

Some recent developments in the helicobacter pylori non-invasive testing market include:

Meridian Bioscience, Inc. announced in March 2020 that its novel Curian and Curian HpSA assay had been approved by the Food and Drug Administration. They hope that their efforts to preserve their position as the industry leader in testing for gastrointestinal diseases would be aided by the introduction of this analyzer and its initial assay.

Thermo Fischer Scientific announced in December 2021 that it would be purchasing PPD, Inc. for US$17.4 billion. PPD is a top global provider of clinical research services to the biopharma & biotech industry.

Key Segments in the Helicobacter Pylori Non-Invasive Testing Market

By Non-invasive Test Type:

  • Serology Test
  • Stool Antigen Test
  • Urea Breath Test

By Test Type:

  • Laboratory-based Tests
  • Point-of-Care Tests

By End-user:

  • Hospitals
  • Diagnostic Labs
  • Clinics

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA (Middle East and Africa)
  • Europe

Frequently Asked Questions

The growth outlook for the Helicobacter Pylori Non-Invasive Testing market is predicted to advance at a CAGR of 4.4% from 2023-to 2033.

Europe region is anticipated to lead the Helicobacter Pylori Non-Invasive Testing market over the forecast period.

The valuation of the Helicobacter Pylori Non-Invasive Testing market stands at US$ 650.50 Mn in 2023.

The Helicobacter Pylori Non-Invasive Testing market is likely to hold a valuation of US$ 1000.57 Mn by 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Test Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Test Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Test Type, 2022-2032

        5.3.1. Serology Test

        5.3.2. Stool Antigen Test (SAT)

        5.3.3. Urea Breath Test (UBT)

    5.4. Y-o-Y Growth Trend Analysis By Test Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Test Type, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Test Method

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Test Method, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Test Method, 2022-2032

        6.3.1. Laboratory-based Tests

        6.3.2. Point-of-Care Tests

    6.4. Y-o-Y Growth Trend Analysis By Test Method, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Test Method, 2022-2032

7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End-user

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By End-user , 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-user , 2022-2032

        7.3.1. Hospitals

        7.3.2. Clinics

        7.3.3. Diagnostic Laboratories

    7.4. Y-o-Y Growth Trend Analysis By End-user , 2017-2021

    7.5. Absolute $ Opportunity Analysis By End-user , 2022-2032

8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. South Asia

        8.3.5. East Asia

        8.3.6. Oceania

        8.3.7. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Test Type

        9.2.3. By Test Method

        9.2.4. By End-user

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Test Type

        9.3.3. By Test Method

        9.3.4. By End-user

    9.4. Key Takeaways

10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Test Type

        10.2.3. By Test Method

        10.2.4. By End-user

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Test Type

        10.3.3. By Test Method

        10.3.4. By End-user

    10.4. Key Takeaways

11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Test Type

        11.2.3. By Test Method

        11.2.4. By End-user

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Test Type

        11.3.3. By Test Method

        11.3.4. By End-user

    11.4. Key Takeaways

12. South Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Malaysia

            12.2.1.3. Singapore

            12.2.1.4. Thailand

            12.2.1.5. Rest of South Asia

        12.2.2. By Test Type

        12.2.3. By Test Method

        12.2.4. By End-user

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Test Type

        12.3.3. By Test Method

        12.3.4. By End-user

    12.4. Key Takeaways

13. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Test Type

        13.2.3. By Test Method

        13.2.4. By End-user

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Test Type

        13.3.3. By Test Method

        13.3.4. By End-user

    13.4. Key Takeaways

14. Oceania Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Test Type

        14.2.3. By Test Method

        14.2.4. By End-user

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Test Type

        14.3.3. By Test Method

        14.3.4. By End-user

    14.4. Key Takeaways

15. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Test Type

        15.2.3. By Test Method

        15.2.4. By End-user

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Test Type

        15.3.3. By Test Method

        15.3.4. By End-user

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. U.S.

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2021

            16.1.2.1. By Test Type

            16.1.2.2. By Test Method

            16.1.2.3. By End-user

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2021

            16.2.2.1. By Test Type

            16.2.2.2. By Test Method

            16.2.2.3. By End-user

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2021

            16.3.2.1. By Test Type

            16.3.2.2. By Test Method

            16.3.2.3. By End-user

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2021

            16.4.2.1. By Test Type

            16.4.2.2. By Test Method

            16.4.2.3. By End-user

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2021

            16.5.2.1. By Test Type

            16.5.2.2. By Test Method

            16.5.2.3. By End-user

    16.6. U.K.

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2021

            16.6.2.1. By Test Type

            16.6.2.2. By Test Method

            16.6.2.3. By End-user

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2021

            16.7.2.1. By Test Type

            16.7.2.2. By Test Method

            16.7.2.3. By End-user

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2021

            16.8.2.1. By Test Type

            16.8.2.2. By Test Method

            16.8.2.3. By End-user

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2021

            16.9.2.1. By Test Type

            16.9.2.2. By Test Method

            16.9.2.3. By End-user

    16.10. India

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2021

            16.10.2.1. By Test Type

            16.10.2.2. By Test Method

            16.10.2.3. By End-user

    16.11. Malaysia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2021

            16.11.2.1. By Test Type

            16.11.2.2. By Test Method

            16.11.2.3. By End-user

    16.12. Singapore

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2021

            16.12.2.1. By Test Type

            16.12.2.2. By Test Method

            16.12.2.3. By End-user

    16.13. Thailand

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2021

            16.13.2.1. By Test Type

            16.13.2.2. By Test Method

            16.13.2.3. By End-user

    16.14. China

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2021

            16.14.2.1. By Test Type

            16.14.2.2. By Test Method

            16.14.2.3. By End-user

    16.15. Japan

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2021

            16.15.2.1. By Test Type

            16.15.2.2. By Test Method

            16.15.2.3. By End-user

    16.16. South Korea

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2021

            16.16.2.1. By Test Type

            16.16.2.2. By Test Method

            16.16.2.3. By End-user

    16.17. Australia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2021

            16.17.2.1. By Test Type

            16.17.2.2. By Test Method

            16.17.2.3. By End-user

    16.18. New Zealand

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2021

            16.18.2.1. By Test Type

            16.18.2.2. By Test Method

            16.18.2.3. By End-user

    16.19. GCC Countries

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2021

            16.19.2.1. By Test Type

            16.19.2.2. By Test Method

            16.19.2.3. By End-user

    16.20. South Africa

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2021

            16.20.2.1. By Test Type

            16.20.2.2. By Test Method

            16.20.2.3. By End-user

    16.21. Israel

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2021

            16.21.2.1. By Test Type

            16.21.2.2. By Test Method

            16.21.2.3. By End-user

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Test Type

        17.3.3. By Test Method

        17.3.4. By End-user

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. DiaSorin S.p.A.

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Meridian Bioscience, Inc.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Exalenz Bioscience Ltd.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Alere

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Thermo Fisher Scientific

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Biomerica, Inc.

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Certest Biotec S.L.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Sekisui Diagnostics

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. CorisBioconcept SPRL

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 3: Global Market Value (US$ Mn) Forecast by Test Method, 2017-2032

Table 4: Global Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 5: North America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 6: North America Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 7: North America Market Value (US$ Mn) Forecast by Test Method, 2017-2032

Table 8: North America Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 9: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Latin America Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 11: Latin America Market Value (US$ Mn) Forecast by Test Method, 2017-2032

Table 12: Latin America Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 13: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Europe Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 15: Europe Market Value (US$ Mn) Forecast by Test Method, 2017-2032

Table 16: Europe Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 17: South Asia Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: South Asia Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 19: South Asia Market Value (US$ Mn) Forecast by Test Method, 2017-2032

Table 20: South Asia Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 21: East Asia Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: East Asia Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 23: East Asia Market Value (US$ Mn) Forecast by Test Method, 2017-2032

Table 24: East Asia Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 25: Oceania Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 26: Oceania Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 27: Oceania Market Value (US$ Mn) Forecast by Test Method, 2017-2032

Table 28: Oceania Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 29: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 30: MEA Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 31: MEA Market Value (US$ Mn) Forecast by Test Method, 2017-2032

Table 32: MEA Market Value (US$ Mn) Forecast by End-user , 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) by Test Type, 2022-2032

Figure 2: Global Market Value (US$ Mn) by Test Method, 2022-2032

Figure 3: Global Market Value (US$ Mn) by End-user , 2022-2032

Figure 4: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 9: Global Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 10: Global Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 11: Global Market Value (US$ Mn) Analysis by Test Method, 2017-2032

Figure 12: Global Market Value Share (%) and BPS Analysis by Test Method, 2022-2032

Figure 13: Global Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032

Figure 14: Global Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 15: Global Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 16: Global Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 17: Global Market Attractiveness by Test Type, 2022-2032

Figure 18: Global Market Attractiveness by Test Method, 2022-2032

Figure 19: Global Market Attractiveness by End-user , 2022-2032

Figure 20: Global Market Attractiveness by Region, 2022-2032

Figure 21: North America Market Value (US$ Mn) by Test Type, 2022-2032

Figure 22: North America Market Value (US$ Mn) by Test Method, 2022-2032

Figure 23: North America Market Value (US$ Mn) by End-user , 2022-2032

Figure 24: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 29: North America Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 30: North America Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 31: North America Market Value (US$ Mn) Analysis by Test Method, 2017-2032

Figure 32: North America Market Value Share (%) and BPS Analysis by Test Method, 2022-2032

Figure 33: North America Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032

Figure 34: North America Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 35: North America Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 36: North America Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 37: North America Market Attractiveness by Test Type, 2022-2032

Figure 38: North America Market Attractiveness by Test Method, 2022-2032

Figure 39: North America Market Attractiveness by End-user , 2022-2032

Figure 40: North America Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Market Value (US$ Mn) by Test Type, 2022-2032

Figure 42: Latin America Market Value (US$ Mn) by Test Method, 2022-2032

Figure 43: Latin America Market Value (US$ Mn) by End-user , 2022-2032

Figure 44: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 51: Latin America Market Value (US$ Mn) Analysis by Test Method, 2017-2032

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Test Method, 2022-2032

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032

Figure 54: Latin America Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 57: Latin America Market Attractiveness by Test Type, 2022-2032

Figure 58: Latin America Market Attractiveness by Test Method, 2022-2032

Figure 59: Latin America Market Attractiveness by End-user , 2022-2032

Figure 60: Latin America Market Attractiveness by Country, 2022-2032

Figure 61: Europe Market Value (US$ Mn) by Test Type, 2022-2032

Figure 62: Europe Market Value (US$ Mn) by Test Method, 2022-2032

Figure 63: Europe Market Value (US$ Mn) by End-user , 2022-2032

Figure 64: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 69: Europe Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 71: Europe Market Value (US$ Mn) Analysis by Test Method, 2017-2032

Figure 72: Europe Market Value Share (%) and BPS Analysis by Test Method, 2022-2032

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032

Figure 74: Europe Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 75: Europe Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 77: Europe Market Attractiveness by Test Type, 2022-2032

Figure 78: Europe Market Attractiveness by Test Method, 2022-2032

Figure 79: Europe Market Attractiveness by End-user , 2022-2032

Figure 80: Europe Market Attractiveness by Country, 2022-2032

Figure 81: South Asia Market Value (US$ Mn) by Test Type, 2022-2032

Figure 82: South Asia Market Value (US$ Mn) by Test Method, 2022-2032

Figure 83: South Asia Market Value (US$ Mn) by End-user , 2022-2032

Figure 84: South Asia Market Value (US$ Mn) by Country, 2022-2032

Figure 85: South Asia Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: South Asia Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 89: South Asia Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 91: South Asia Market Value (US$ Mn) Analysis by Test Method, 2017-2032

Figure 92: South Asia Market Value Share (%) and BPS Analysis by Test Method, 2022-2032

Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032

Figure 94: South Asia Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 95: South Asia Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 96: South Asia Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 97: South Asia Market Attractiveness by Test Type, 2022-2032

Figure 98: South Asia Market Attractiveness by Test Method, 2022-2032

Figure 99: South Asia Market Attractiveness by End-user , 2022-2032

Figure 100: South Asia Market Attractiveness by Country, 2022-2032

Figure 101: East Asia Market Value (US$ Mn) by Test Type, 2022-2032

Figure 102: East Asia Market Value (US$ Mn) by Test Method, 2022-2032

Figure 103: East Asia Market Value (US$ Mn) by End-user , 2022-2032

Figure 104: East Asia Market Value (US$ Mn) by Country, 2022-2032

Figure 105: East Asia Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: East Asia Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 109: East Asia Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 111: East Asia Market Value (US$ Mn) Analysis by Test Method, 2017-2032

Figure 112: East Asia Market Value Share (%) and BPS Analysis by Test Method, 2022-2032

Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032

Figure 114: East Asia Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 115: East Asia Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 116: East Asia Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 117: East Asia Market Attractiveness by Test Type, 2022-2032

Figure 118: East Asia Market Attractiveness by Test Method, 2022-2032

Figure 119: East Asia Market Attractiveness by End-user , 2022-2032

Figure 120: East Asia Market Attractiveness by Country, 2022-2032

Figure 121: Oceania Market Value (US$ Mn) by Test Type, 2022-2032

Figure 122: Oceania Market Value (US$ Mn) by Test Method, 2022-2032

Figure 123: Oceania Market Value (US$ Mn) by End-user , 2022-2032

Figure 124: Oceania Market Value (US$ Mn) by Country, 2022-2032

Figure 125: Oceania Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 128: Oceania Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 129: Oceania Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 131: Oceania Market Value (US$ Mn) Analysis by Test Method, 2017-2032

Figure 132: Oceania Market Value Share (%) and BPS Analysis by Test Method, 2022-2032

Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032

Figure 134: Oceania Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 135: Oceania Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 137: Oceania Market Attractiveness by Test Type, 2022-2032

Figure 138: Oceania Market Attractiveness by Test Method, 2022-2032

Figure 139: Oceania Market Attractiveness by End-user , 2022-2032

Figure 140: Oceania Market Attractiveness by Country, 2022-2032

Figure 141: MEA Market Value (US$ Mn) by Test Type, 2022-2032

Figure 142: MEA Market Value (US$ Mn) by Test Method, 2022-2032

Figure 143: MEA Market Value (US$ Mn) by End-user , 2022-2032

Figure 144: MEA Market Value (US$ Mn) by Country, 2022-2032

Figure 145: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 148: MEA Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 149: MEA Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 150: MEA Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 151: MEA Market Value (US$ Mn) Analysis by Test Method, 2017-2032

Figure 152: MEA Market Value Share (%) and BPS Analysis by Test Method, 2022-2032

Figure 153: MEA Market Y-o-Y Growth (%) Projections by Test Method, 2022-2032

Figure 154: MEA Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 155: MEA Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 156: MEA Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 157: MEA Market Attractiveness by Test Type, 2022-2032

Figure 158: MEA Market Attractiveness by Test Method, 2022-2032

Figure 159: MEA Market Attractiveness by End-user , 2022-2032

Figure 160: MEA Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Cystatin C Testing Market

Published : March 2022

Healthcare

Helicobacter Pylori Testing Market

Published : October 2017

Google translate

Helicobacter Pylori Non-Invasive Testing Market